Multiple Myeloma: Iberdomide with Isatuximab

We are studying whether adding isatuximab to iberdomide helps patients with newly diagnosed multiple myeloma achieve better treatment outcomes after stem cell transplantation.

>2 years Confirmation phase (III)No Placebo Investigational Medicines Oral InjectionHematologyOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Dexamethason Tad

Dexamethason Tad is a steroid medicine used to reduce inflammation and calm an overactive immune response in conditions like allergies, asthma, and arthritis.

Pomalidomide

Pomalidomide is a medicine used to treat multiple myeloma, a type of blood cancer.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Dexamethasone

Dexamethasone is a steroid that reduces inflammation and suppresses the immune system to treat allergic, inflammatory, and autoimmune conditions.

Isatuximab

Isatuximab is a substance that helps the immune system target and destroy cancerous plasma cells in multiple myeloma.

Pomalidomide

Pomalidomide is a substance used to treat certain blood cancers by helping control abnormal plasma cell growth and modulating the immune system.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Iberdomide

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Amelinor

Axium

Cloradex

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Universitaetsklinikum Krems

Universitätsklinikum Krems, Innere Medizin II Hämato-Onkologie

Krems an der Donau, Austria

Ordensklinikum Linz GmbH

Ordensklinikum Linz Elisabethinen Abteilung 1. Interne / Onkologie / Hämatologie)

Linz, Austria

SCRI CCCIT Ges.m.b.H.

Universitätsklinik für Innere Medizin III

Salzburg, Austria

Sponsor: Universitaetsklinikum Heidelberg AöR

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.